NCT07452432 2026-03-05
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Samsung Medical Center
Recruiting
Clinical Trials
74 trialsNCT07441499 2026-03-02
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Tianjin Medical University Second Hospital
Recruiting
NCT06412848 2026-02-24
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Active not recruiting
NCT06657157 2026-02-24
P-EVOLUTION
Comprehensive Cancer Center Munich (CCCM)
Recruiting
NCT06138561 2026-02-17
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Dana-Farber Cancer Institute
Recruiting
NCT06724159 2026-02-17
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
Recruiting
NCT07390617 2026-02-05
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center
Recruiting
NCT07386847 2026-02-04
A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer
Pfizer
Not yet recruiting
NCT07339878 2026-01-14
FLORAL
University Hospital, Strasbourg, France
Recruiting
NCT07334314 2026-01-12
OUAF
University Hospital, Strasbourg, France
Recruiting
NCT03782207 2026-01-08
IMreal
Hoffmann-La Roche
Active not recruiting
NCT06870253 2026-01-06
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Pangea Laboratory LLC
Active not recruiting
NCT06120374 2025-12-30
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Recruiting
NCT06129084 2025-12-15
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
British Columbia Cancer Agency
Active not recruiting
NCT07037589 2025-11-21
BLUSH
Vastra Gotaland Region
Recruiting
NCT05889195 2025-10-31
microDRIVE
Pacific Edge Limited
Recruiting
NCT06396533 2025-10-31
INSITE
Fox Chase Cancer Center
Recruiting
NCT06310759 2025-10-10
UROSCOUT-1
Tampere University Hospital
Recruiting
NCT03374267 2025-09-22
CARAT
iOMEDICO AG
Recruiting
NCT04892849 2025-09-17
ST-ICI02
University of Erlangen-Nürnberg Medical School
Recruiting
NCT07072637 2025-07-18
Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy
National Taiwan University Hospital
Not yet recruiting
NCT06421311 2025-06-05
URADJ
Bristol-Myers Squibb
Terminated
NCT06982794 2025-05-21
Urolife
IRCCS San Raffaele
Recruiting
NCT05945108 2025-04-11
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca
Completed
NCT06912672 2025-04-08
UMT-UC
Shanghai Epiprobe Biotechnology Co., Ltd.
Not yet recruiting
NCT05431777 2025-04-01
A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Completed
NCT05874921 2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
NCT05337189 2025-02-13
A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Recruiting
NCT04822350 2025-01-27
AVENANCE
Pfizer
Completed
NCT04970472 2024-12-11
MicroBlad
University Hospital, Toulouse
Recruiting
NCT06663735 2024-10-29
Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
The First Affiliated Hospital of Xinxiang Medical College
Not yet recruiting
NCT06564363 2024-08-21
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd
Unknown
NCT06469229 2024-07-05
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
Changhai Hospital
Not yet recruiting
NCT06427993 2024-06-20
Urine DNA Methylation Detection for Hematuria Evaluation
Changhai Hospital
Not yet recruiting
NCT05699135 2024-04-24
TRAVELER
Pfizer
Terminated
NCT04641936 2024-04-17
Urine Omics Predicting IO Therapy Responses in mUC Patients
National Taiwan University Hospital
Recruiting
NCT06321640 2024-03-20
POSITive
European Institute of Oncology
Recruiting
NCT03788746 2024-02-22
PREVAIL
AstraZeneca
Completed
NCT04943380 2024-02-02
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Pacific Edge Limited
Unknown
NCT06193941 2024-01-09
Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits
Zhongnan Hospital
Completed
NCT06169904 2023-12-14
B7-Family Score in Urothelial Carcinoma
Shanghai Zhongshan Hospital
Completed
NCT06116396 2023-11-07
CIRCE
IRCCS San Raffaele
Recruiting
NCT06120413 2023-11-07
18F-LN1 PET/CT in Urothelial Carcinomas
Sichuan Provincial People's Hospital
Unknown
NCT06113367 2023-11-02
VESUVIO
Assistance Publique - Hôpitaux de Paris
Unknown
NCT04314245 2023-05-24
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma
AnchorDx Medical Co., Ltd.
Completed
NCT03330886 2023-03-13
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
Hoffmann-La Roche
Completed
NCT05052372 2022-12-22
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
xCures
Terminated
NCT05503563 2022-08-16
A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder
Assiut University
Unknown
NCT04718948 2022-05-09
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
University of Florence
Unknown
NCT04770974 2022-05-09
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
University of Florence
Unknown